Lapam leads Canbridge's $25M series B

On May 23, Canbridge Life Sciences Ltd. (Beijing, China) raised $25 million in a series B round led by Lapam Capital. Also participating were Qiming Venture Partners, Yuanming Capital, Yanyuan Capital, Biossom Investment Management and WuXi AppTec Co. Ltd. (Shanghai, China)...